EKF is a leading global diagnostics and biotechnology company specializing in the development, production, and distribution of innovative medical technologies and patient-centric solutions.
EKF delivers diagnostic technologies and biotechnology solutions that empower healthcare and medical providers to make informed clinical decisions through point-of-care testing and life sciences applications.
EKF is listed on the London Stock Exchange's AIM market.
EKF Point of Care (POC) analyzers are designed for use within doctors' surgeries, clinics, blood banks and hospital and private laboratories to provide fast and accurate results at an affordable price.
EKF Central Laboratory division manufactures a wide spectrum of reagents for use in hospital laboratories. It also supplies benchtop automated and semi-automated analysers, as well as centrifuges and some rapid test kits.
EKF Life Sciences specializes in producing enzymes and contracted custom products for use in medical diagnostics, pharmaceuticals and industry. EKF Life Science facilities are based in two locations in Indiana, USA.
EKF Contract Manufacturing provides specialized services to the diagnostics and healthcare industries for the production of custom kits. With facilities in the US, UK and Germany EKF is able to provide bulk formulation, dispensing and kitting services, as well as provide advice and guidance on Regulatory requirements. EKF's end-to-end service also includes sourcing, print and compilation of packaging, IFUs and labelling.
EKF Diagnostics' Quo-Test analyzer has been designed for easy and reliable HbA1c measurement for the detection and management of diabetes in a point-of-care setting such as diabetes clinics and doctors’ surgeries.
The Quo-Test HbA1c is a fully automated hemoglobin A1c analyzer that uses patented boronate fluorescence quenching technology to measure glycated hemoglobin from a 4 μl sample taken from a finger prick or venous whole blood.
Sample results are available within four minutes and are reported in IFCC and DCCT standards (Mono S & JDS reporting are also available). Quo-Test is unaffected by most hemoglobin variants.
Quo-Test can store up to 7,000 results which can be downloaded as text files to a PC via the integrated USB interface. Alternatively, results can be printed using a printer which connects via a serial port.
Quo-Test’s step by step instructions are displayed on its clear, multi-lingual display. Staff training time can therefore be minimised and the opportunity for error is reduced.
Quo-Test is CE marked and has been approved by China's CFDA for the monitoring of HbA1c in diabetes patients.
Hemoglobin is an iron containing molecule present in red blood cells that is responsible for transporting oxygen around the body. Glucose can bind irreversibly to hemoglobin via a process known as glycation. Hemoglobin that has glucose attached is known as glycated hemoglobin, often abbreviated to HbA1c or simply A1c.
Because red blood cells have a life span of 120 days (three months) measuring the level of glycated hemoglobin in blood effectively shows the average blood glucose level for the previous 6-8 weeks. In conjunction with regular blood glucose monitoring diaries, A1c tests can aid care providers in determining if a patient's treatment plan needs altering in any way to better control blood glucose levels.
Quo-Test uses boronate fluorescence quenching, a patented technology, to deliver HbA1c results in four minutes. The video demonstrates how boronate fluorescence quenching technology measures glycated hemoglobin (HbA1c) from whole blood samples.
EKF is a leading point-of-care diagnostics and central laboratory assay manufacturer with an estimated 80,000 hemoglobin, hematocrit, HbA1c, glucose and lactate analyzers in regular use across more than 100 countries.
EKF specialises in developing tests for use in diabetes and anemia diagnosis and management, as well as providing a portfolio of reagents for use in clinical chemistry analyzers. During the COVID-19 pandemic EKF developed and expanded its contract manufacturing capabilities in three countries to be able to provide a full suite of services to third party customers.
The EKF range of HbA1c analyzers and glucose analyzers deliver fast and reliable results that provide both diabetes practitioners and patients with the information they need to make clinical or lifestyle decisions in minutes.
EKF offers an extensive range of hemoglobin and hematocrit analyzers that provide physicians, blood bank professionals, and nutritional and paediatric nurses with fast and accurate results they can rely on. Choose between analyzers with different measuring methodology, features and connectivity options to suit your budget and requirements.
The EKF women’s health range aims to improve healthcare outcomes for women and children by providing physicians with a suite of products including pregnancy testing, anemia screening, fetal scalp lactate testing and post birth creamatocrit measurement.
Train like the best. Track athlete performance over time with regular lactate testing using Biosen C-Line. As used by leading athletic institutes and world famous soccer clubs throughout Europe.
EKF Diagnostics is also a global manufacturer of central laboratory products including Stanbio Chemistry reagents, benchtop laboratory analyzers, rapid tests and centrifuges. Stanbio chemistry reagents can be used on the majority of analyzers found in hospital laboratories around the world.
EKF Life Sciences' has been offering high quality enzyme fermentation and contract manufacturing services for over 20 years. Our facilities in Elkhart and South Bend, Indiana, are designed to produce a wide range of clinically important enzymes used in many diagnostic applications. EKF Life Sciences contract fermentation enzymes can be provided either in bulk or supplied in customer branded packaging.
EKF provides tailored services for third party business seeking to outsource their bulk formulation, kitting and logistics requirements. With sites across three countries, including multiple locations in the USA, EKF is able to provide scalable manufacturing solutions as well as advice on regulatory and marketing issues that often provide significant challenges to businesses.
“EKF is one of the most responsive medical device suppliers we have ever worked with as a distributor. For us it has been an absolute pleasure to work with EKF Sales and marketing team for the last 10 years. Staff changes, level of service remains high. The open and friendly communication with sales and logistics, backed by excellent marketing support and technical service helps us to easily overcome the challenges we face with on our local market. Our customers are delighted with their best-in-class Biosen devices for measuring glucose and lactate. In my opinion, the Biosen product is unbeatable for the moment”
Ganka Pavlova
EKF Distributor in Bulgaria
“We distribute the Hemo Control product in Peru and we find it to be a very reliable, resistance and versatile product that works brilliantly for us. Peru is a country of difficult geography and our teams have had to endure extreme cold, unbearable heat and vast differences in altitude (from sea-level right up to 4,500 meters). The Hemo Control analyzers are installed in sea-level establishments operating in temperatures over 35°C and in the mountains, at more than 4,500 meters above sea level at far lower temperatures. We also have establishments in the jungle, with the Hemo Control operating in the hot and humid climate”
David Gallo
EKF Distributor in Peru
"We have been enjoying working with EKF Diagnostics as their distributor in the Philippines for more than 5 years. They have good quality products that satisfy our clients, and they have a top notch sales and support team"
Maristel Lim
EKF Distributor in Philippines
We have written a series of guides to help medical professionals understand more about point-of-care testing for anemia, diabetes, ketosis and lactate measurement.
Find out more about the different methods for testing, the symptoms, the associated conditions and understand how POCT can help deliver accurate results in minutes.
EKF Diagnostics Holdings plc is listed on the London Stock Exchange. The ordinary shares are traded on the AIM market. For Investor Announcements, Company information and background to the Board of Directors and Advisors view the Investors section of this website.
Copyright © 2024 | Powered by Intergage
Please note: Not all products are available in all countries. Please check availability.
Newsletter
Keep up to date with all our activities, events, exhibitions, promotions, investor news & more.